What are the criteria for mitral valve replacement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Criteria for Mitral Valve Replacement

Mitral valve surgery is indicated for symptomatic patients with severe mitral regurgitation (MR) and LVEF >30%, and for asymptomatic patients with left ventricular dysfunction (LVESD ≥45 mm and/or LVEF ≤60%), with repair strongly preferred over replacement when durable results are expected. 1

Primary Mitral Regurgitation

The 2017 ESC/EACTS guidelines provide clear thresholds for intervention 1:

Class I Indications for Surgery:

  • Symptomatic patients with severe primary MR and LVEF >30%
  • Asymptomatic patients with LV dysfunction defined as:
    • LVESD ≥45 mm, OR
    • LVEF ≤60%
  • Patients undergoing CABG or other cardiac surgery

Critical principle: Mitral valve repair should be the preferred technique when durable results are expected 1. This is not merely a suggestion—repair consistently demonstrates superior outcomes compared to replacement, particularly in younger patients and those with preserved ventricular function.

Secondary (Functional) Mitral Regurgitation

For secondary MR, the indications are more restrictive 1:

  • Surgery indicated in patients with severe secondary MR undergoing CABG and LVEF >30%
  • The decision becomes complex when isolated secondary MR is present, requiring Heart Team evaluation

The 2020 ACC/AHA guidelines emphasize that secondary MR may not improve after isolated valve surgery, and outcomes are less predictable 2. This represents a key clinical pitfall—assuming that correcting the valve will resolve functional MR when the underlying problem is ventricular remodeling.

Mitral Stenosis

For clinically significant mitral stenosis (valve area ≤1.5 cm²) 1:

Surgical Indications:

  • Symptomatic patients who are not suitable for percutaneous mitral commissurotomy (PMC)
  • Patients with unfavorable valve characteristics for PMC include:
    • Heavy valve calcification
    • Significant mitral regurgitation
    • Poor valve mobility
    • Extensive subvalvular disease

PMC should be attempted first in suitable candidates, making surgery a second-line option for stenosis 1.

Age-Specific Considerations for Repair vs. Replacement

Recent evidence challenges traditional age cutoffs for bioprosthetic valves 3, 4:

For patients <65 years:

  • Repair is strongly preferred (HR for death with replacement: 3.0; p=0.007) 4
  • This survival advantage is most pronounced in:
    • Ischemic etiology
    • Poor EF (<30%)
    • Severe LV dilatation (LVEDD >60mm)
    • Presence of atrial fibrillation

For patients 65-75 years:

  • Repair still shows survival benefit (HR 1.7 for replacement; p=0.04) 4

For patients >75 years:

  • No significant difference between repair and replacement 4

When Replacement is Necessary

Replacement becomes mandatory when 5:

  • Extensive loss of pliable leaflet area
  • Severe leaflet thickening and calcification
  • Small annuli with multiple complex leaflet defects
  • Repair attempts have low probability of durability
  • Active endocarditis with extensive tissue destruction requiring debridement

Common Pitfalls to Avoid

  1. Waiting too long in asymptomatic patients: Once LVESD reaches 45mm or LVEF drops to 60%, irreversible LV dysfunction may develop
  2. Assuming secondary MR will improve after isolated valve surgery: It frequently persists or worsens 2
  3. Choosing replacement over repair in younger patients: This significantly increases long-term mortality 4
  4. Operating on patients with LVEF <30%: These patients have prohibitively high operative mortality unless undergoing concomitant revascularization

Prosthesis Selection (When Replacement Required)

Mechanical valve favored when 1:

  • Patient desires it after informed consent
  • No contraindication to anticoagulation
  • Risk of accelerated structural valve deterioration (young age, renal failure, hyperparathyroidism)

Bioprosthetic valve favored when 1:

  • Anticoagulation contraindicated or unreliable
  • Patient preference
  • Age considerations (though recent data suggests bioprosthetic durability is better than previously thought, even in younger patients) 3

References

Related Questions

In a 22-year-old patient with sore throat and bilateral tonsillar exudates, without cough or fever, what are the next steps in management?
In a stable 26-year-old patient involved in a motor vehicle crash with intact airway, breathing, circulation, normal secondary survey, and Glasgow Coma Scale 15, what is the appropriate emergency department management?
What is the appropriate evaluation and management for an 11-year-old who exhibits severe aggression, such as breaking windows and running away when angry?
Is a blood pressure of 146/84 mm Hg an indication to start antihypertensive medication?
In a 30-year-old male who has undergone roughly 30 venipunctures and 15 intravenous insertions over several years, what is the likelihood of permanent forearm venous damage?
How should I apply the Advanced Trauma Life Support (ATLS) protocol to assess and manage a trauma patient?
What is the recommended protocol for microneedling treatment of alopecia areata in healthy adults without contraindications?
How does ashwagandha lower cortisol?
How does excess histamine contribute to attention deficits and what management strategies can improve concentration?
Should I be concerned about anisocoria after a head injury?
Which non‑sedating antihistamines can be used without impairing attention or causing drowsiness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.